Vantage Biosciences is an ALSA Ventures company at the forefront of targeting the root cause of vision loss associated with diabetes.
Investors 1
| Date | Name | Website |
| 21.07.2023 | ALSA Ventu... | alsaventur... |
Mentions in press and media 1
| Date | Title | Description |
| 19.07.2023 | ALSA Ventures launches Vantage Biosciences to treat Diabetic Eye Disease | · Diabetic eye diseases are the leading cause of blindness in the working age population |